share_log

Assessing Medpace Hldgs: Insights From 9 Financial Analysts

Benzinga ·  Sep 28 01:00

In the latest quarter, 9 analysts provided ratings for Medpace Hldgs (NASDAQ:MEDP), showcasing a mix of bullish and bearish perspectives.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings23400
Last 30D00100
1M Ago01100
2M Ago00100
3M Ago22100

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $402.67, a high estimate of $469.00, and a low estimate of $336.00. A decline of 7.99% from the prior average price target is evident in the current average.

1727456454_0.png

Exploring Analyst Ratings: An In-Depth Overview

A clear picture of Medpace...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment